Camlin Fine Sciences Reports Q1 FY26 Consolidated Results; Focus Shifts to Three Key Operating Segments
Camlin Fine Sciences Limited announced the Un-audited Financial Results (Consolidated and Standalone) for the quarter ended June 30, 2026. The company's Board of Directors approved these results during a meeting held on August 11, 2026. The results reflect the transition in management strategy to report performance across three distinct business segments.The consolidated financials show figures from the Q1 quarter ended June 30, 2026, compared against previous periods. Total revenue from operations for the company stood at 5,198.79 million in the quarter. Total income was reported at 5,212.19 million for the same period.
Regarding profitability, Profit/ (Loss) before tax from continuing operations totaled (322.59) million, while total profit for the period reached 235.43 million.
The company has adopted a three-segment reporting structure to provide a clearer analysis of its financial performance, moving beyond the previous focus on a single specialty chemical business segment. The identified segments are Specialty Ingredients, Aroma, and Performance Chemicals & Others.
Q1 FY26 Financial Highlights (Consolidated)
The following table summarizes key consolidated unaudited figures for Camlin Fine Sciences Limited for the quarter ended June 30, 2026:| Particulars | Consolidated Qtr Ended Jun 30, 2026 (Rs. in Million) |
|---|---|
| Revenue from Operations | 5,198.79 |
| Total Income | 4,487.23 |
| Profit/ (Loss) before tax from continuing operations | (322.59) |
| Total Profit for the period after tax | 235.43 |
Segment Performance Analysis
The reporting segments evaluated include Specialty Ingredients, Aroma, and Performance Chemicals & Others. Operational results in these segments were examined based on operational EBITDA, excluding foreign exchange gain/loss.Segment-wise performance metrics for Q1 ended June 30, 2026 (Unaudited) are detailed below:
| Segment | Revenue from Operations (Rs. in Million) | Segment Results before Exceptional Items (Rs. in Million) |
|---|---|---|
| Specialty Ingredients | 4,013.17 | 176.44 |
| Aroma | 774.07 | (33.81) |
| Performance Chemicals & Others | 1,389.52 | (44.41) |
Management noted that the fire incident at one of its wholly owned subsidiaries resulted in a shortfall of Rs. 108.8 million arising from an insurance claim settlement related to the incident that occurred on February 7, 2026, but management does not expect any residual loss from the incident.
The company's management confirmed that all inter-segment transactions are conducted at normal commercial terms and in line with the annual accounting principle.
CAMLINFINE Stock Price Movement
Today, Camlin Fine Sciences Limited shares edged higher to settle at ₹125.50, reflecting a solid performance as the market closed. The stock finished the trading day after recording a total volume of 555,185 shares during its session.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.